Predictors of exacerbations of asthma and COPD during one year in primary care

Aims. To investigate the incidence of asthma and chronic obstructive pulmonary disease (COPD) exacerbations in primary care during one year and to identify risk factors for such events. Methods. The study was carried out at seven general practice offices in Norway. Patients aged 40 years or more registered with a diagnosis of asthma and/or COPD the previous 5 years were included. After a baseline examination, the participants consulted their GP during exacerbations for the following 12 months. A questionnaire on exacerbations during the follow-up year was distributed to all. Univariable and multivariable logistic regression was performed to determine predictors of future exacerbations. Results. Three hundred and eighty patients attended the baseline examination and complete follow-up data were retrieved from 340 patients. COPD as defined by forced expiratory volume in the first second of expiration/forced vital capacity (FEV1/FVC) < 0.7, was found in 132 (38.8%) patients. One hundred and fifty-nine patients (46.8%) experienced one exacerbation or more and 101 (29.7%) two exacerbations or more. Patients who had an exacerbation treated with antibiotics or systemic corticosteroids or leading to hospitalization the year before baseline (N = 88) had the highest risk of getting an exacerbation during the subsequent year (odds ratio 9.2), whether the FEV1/FVC was below 0.7 or not. Increased risk of future exacerbations was also related to age ≥ 65 years and limitations in social activities, but not to the FEV1. Conclusions. The study confirms that previous exacerbations strongly predict future exacerbations in patients with COPD or asthma. Identification and a closer follow-up of patients at risk of such events could promote earlier treatment when necessary and prevent a rapid deterioration of their condition.

[1]  P. Gibson,et al.  The Asthma Control Test and Asthma Control Questionnaire for assessing asthma control: Systematic review and meta-analysis. , 2013, The Journal of allergy and clinical immunology.

[2]  F. Martinez,et al.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. , 2007, American journal of respiratory and critical care medicine.

[3]  Joan B. Soriano,et al.  Treatment of COPD by clinical phenotypes: putting old evidence into clinical practice , 2012, European Respiratory Journal.

[4]  M. Miravitlles,et al.  The overlap phenotype: the (missing) link between asthma and COPD , 2012, Multidisciplinary Respiratory Medicine.

[5]  M. Mishima,et al.  Association between Episodes of Upper Respiratory Infection and Exacerbations in Adult Patients with Asthma , 2012, The Journal of asthma : official journal of the Association for the Care of Asthma.

[6]  H. Ortega,et al.  Characterization of Asthma Exacerbations in Primary Care Using Cluster Analysis , 2012, The Journal of asthma : official journal of the Association for the Care of Asthma.

[7]  H. Reddel,et al.  American Thoracic Society , 2001 .

[8]  H. Melbye,et al.  Asthma, chronic obstructive pulmonary disease, or both? Diagnostic labeling and spirometry in primary care patients aged 40 years or more , 2011, International journal of chronic obstructive pulmonary disease.

[9]  D. DeMeo,et al.  Clinical predictors of frequent exacerbations in subjects with severe chronic obstructive pulmonary disease (COPD). , 2011, Respiratory medicine.

[10]  A. Anzueto Primary Care Management of Chronic Obstructive Pulmonary Disease to Reduce Exacerbations and Their Consequences , 2010, The American journal of the medical sciences.

[11]  J. Wedzicha,et al.  Susceptibility to exacerbation in chronic obstructive pulmonary disease. , 2010, The New England journal of medicine.

[12]  J. Potter,et al.  UK National COPD Resources and Outcomes Project (NCROP): 2008 National Audit Data Presents An Opportunity to Highlight the Areas for Improvement in COPD Care in the Ageing Population , 2010, COPD.

[13]  José Miguel Rodríguez-González-Moro,et al.  Misdiagnosis of patients receiving inhaled therapies in primary care , 2010, International journal of chronic obstructive pulmonary disease.

[14]  R. Hubbard,et al.  Increased risk of myocardial infarction and stroke following exacerbation of COPD. , 2010, Chest.

[15]  I. Pavord,et al.  An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice. , 2009, American journal of respiratory and critical care medicine.

[16]  B. Ställberg,et al.  Validation of the Clinical COPD Questionnaire (CCQ) in primary care , 2009, Health and quality of life outcomes.

[17]  Sally E Wenzel,et al.  Recent asthma exacerbations: a key predictor of future exacerbations. , 2007, Respiratory medicine.

[18]  B. Celli,et al.  Impact of COPD exacerbations on patient-centered outcomes. , 2007, Chest.

[19]  Wu Da-we Pulmonary Disease(COPD) , 2007 .

[20]  S. Wenzel,et al.  TENOR risk score predicts healthcare in adults with severe or difficult-to-treat asthma , 2006, European Respiratory Journal.

[21]  Angela E. Williams,et al.  Defining COPD exacerbations: impact on estimation of incidence and burden in primary care. , 2006, Primary care respiratory journal : journal of the General Practice Airways Group.

[22]  D. Niewoehner The impact of severe exacerbations on quality of life and the clinical course of chronic obstructive pulmonary disease. , 2006, The American journal of medicine.

[23]  T. Welte,et al.  Asthma and COPD. , 2006, Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie.

[24]  C. Lenfant,et al.  Global Initiative for chronic obstructive lung disease. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease , 2006 .

[25]  M. Hoogendoorn,et al.  Severity distribution of chronic obstructive pulmonary disease (COPD) in Dutch general practice. , 2006, Respiratory medicine.

[26]  M. Martínez-García,et al.  with chronic obstructive pulmonary disease Severe acute exacerbations and mortality in patients , 2006 .

[27]  J. Hankinson,et al.  Standardisation of spirometry , 2005, European Respiratory Journal.

[28]  M. Martínez-García,et al.  Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease , 2005, Thorax.

[29]  S. Guerra Overlap of asthma and chronic obstructive pulmonary disease , 2005, Current opinion in pulmonary medicine.

[30]  S. Spencer,et al.  Impact of preventing exacerbations on deterioration of health status in COPD , 2004, European Respiratory Journal.

[31]  T. Seemungal,et al.  Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease , 2002, Thorax.

[32]  W. Bailey,et al.  Editorial: Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2023 Guidelines for COPD, Including COVID-19, Climate Change, and Air Pollution , 2023, Medical science monitor : international medical journal of experimental and clinical research.

[33]  V. Plaza,et al.  Costs of asthma according to the degree of severity. , 1998, The European respiratory journal.

[34]  T. Seemungal,et al.  Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. , 1998, American journal of respiratory and critical care medicine.